procainamide has been researched along with Anomalous Ventricular Excitation Syndrome in 103 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of intravenous procainamide (n = 30) or propafenone (n = 25) were evaluated in 55 patients with acute atrial fibrillation and the Wolff-Parkinson-White syndrome." | 9.06 | Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: importance of atrial fibrillatory cycle length. ( Boahene, KA; Fujimura, O; Klein, GJ; Sharma, AD; Yee, R, 1990) |
| "The objective of this review is to explore and challenge the superiority of amiodarone for rate control in Wolff-Parkinson-White syndrome and concomitant atrial fibrillation (WPW-AF)." | 8.86 | Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation. ( Langdorf, MI; Lotfipour, S; Simonian, SM; Wall, C, 2010) |
| "A patient with the Wolff-Parkinson-White syndrome presented with incessant orthodromic atrioventricular tachycardia following initiation of procainamide therapy." | 7.67 | Procainamide-induced incessant supraventricular tachycardia in the Wolff-Parkinson-White syndrome. ( Abbott, JA; Davis, JC; Eldar, M; Griffin, JC; Ruder, MA; Scheinman, MM; Seger, J, 1986) |
| "Persistence of preexcitation in sinus rhythm with procainamide infusion has been reported to occur in patients with a short anterograde accessory pathway effective refractory period (AERPAP) and this test has been proposed as a reliable noninvasive method to identify patients with the Wolff-Parkinson-White syndrome who are at risk of sudden death." | 7.67 | Procainamide infusion test: inability to identify patients with Wolff-Parkinson-White syndrome who are potentially at risk of sudden death. ( Fananapazir, L; Gallagher, JJ; German, LD; Greer, GS; Packer, DL; Pressley, JC; Prystowsky, EN, 1988) |
| "In patients with the Wolff-Parkinson-White syndrome, intravenous ajmaline (50 mg administered over 3 minutes) or procainamide (10 mg/kg body weight administered over 10 minutes) is helpful in defining the duration of the anterograde effective refractory period of the accessory pathway." | 7.66 | Value of the ajmaline-procainamide test to predict the effect of long-term oral amiodarone on the anterograde effective refractory period of the accessory pathway in the Wolff-Parkinson-White syndrome. ( Braat, S; Brugada, P; Dassen, WR; Gorgels, AP; Wellens, HJ, 1983) |
| "Like ajmaline, procainamide can be used to identify patients with the Wolff-Parkinson-White syndrome who have a short refractory period of the accessory pathway in an anterograde direction." | 7.66 | Use of procainamide in patients with the Wolff-Parkinson-White syndrome to disclose a short refractory period of the accessory pathway. ( Bär, FW; Braat, S; Brugada, P; Gorgels, AP; Wellens, HJ, 1982) |
| "Thirty-three patients with Wolff-Parkinson-White syndrome were studied electrophysiologically before and after administration of intravenous procainamide and oral quinidine sulfate." | 7.65 | Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome. ( Bashore, TM; Campbell, RW; Gallagher, JJ; Sellers, TD, 1977) |
| " Circus tachycardia was induced by atrial stimulation only after the administration of procainamide." | 7.65 | Wolff-Parkinson-White syndrome. Circus movement tachycardia dependent on procainamide. ( Geddes, JS, 1977) |
| " The effect of procainamide on the anterograde effective refractory period of the accessory pathway was dose dependent; patients who lost preexcitation had a steeper dose-response curve." | 5.28 | Value of a revised procainamide test in the Wolff-Parkinson-White syndrome. ( Boahene, KA; Fujimura, O; Klein, GJ; Sharma, AD; Yee, R, 1990) |
| "During AF in WPW syndrome, the ventricular rate is related to the duration of the anterograde refractory period of the accessory pathway." | 5.27 | Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome. ( Abdollah, H; Brugada, P; Wellens, HJ, 1983) |
| "The effects of intravenous procainamide (n = 30) or propafenone (n = 25) were evaluated in 55 patients with acute atrial fibrillation and the Wolff-Parkinson-White syndrome." | 5.06 | Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: importance of atrial fibrillatory cycle length. ( Boahene, KA; Fujimura, O; Klein, GJ; Sharma, AD; Yee, R, 1990) |
| "The objective of this review is to explore and challenge the superiority of amiodarone for rate control in Wolff-Parkinson-White syndrome and concomitant atrial fibrillation (WPW-AF)." | 4.86 | Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation. ( Langdorf, MI; Lotfipour, S; Simonian, SM; Wall, C, 2010) |
| "Intermittent preexcitation, block in the accessory pathway after intravenous injection of ajmaline or procainamide, and block in the accessory pathway during exercise usually exclude a short antegrade refractory period of an accessory pathway in patients with the Wolff-Parkinson-White syndrome." | 3.67 | Evaluation of noninvasive tests for identifying patients with preexcitation syndrome at risk of rapid ventricular response. ( Coltorti, F; Condorelli, M; Critelli, G; Gallagher, JJ; Monda, V; Perticone, F, 1984) |
| "A patient with the Wolff-Parkinson-White syndrome presented with incessant orthodromic atrioventricular tachycardia following initiation of procainamide therapy." | 3.67 | Procainamide-induced incessant supraventricular tachycardia in the Wolff-Parkinson-White syndrome. ( Abbott, JA; Davis, JC; Eldar, M; Griffin, JC; Ruder, MA; Scheinman, MM; Seger, J, 1986) |
| "Noninvasive stress and pharmacologic tests with procainamide and propafenone were studied as methods to identify patients with Wolff-Parkinson-White syndrome (WPW) who would otherwise be judged at risk of sudden death on the basis of electrophysiologic criteria: the shortest RR interval during induced atrial fibrillation less than or equal to 250 ms or accessory pathway anterograde effective refractory period less than or equal to 250 ms." | 3.67 | Stress and pharmacologic tests as methods to identify patients with Wolff-Parkinson-White syndrome at risk of sudden death. ( Brusca, A; Gaita, F; Giustetto, C; Mangiardi, L; Riccardi, R, 1989) |
| "Persistence of preexcitation in sinus rhythm with procainamide infusion has been reported to occur in patients with a short anterograde accessory pathway effective refractory period (AERPAP) and this test has been proposed as a reliable noninvasive method to identify patients with the Wolff-Parkinson-White syndrome who are at risk of sudden death." | 3.67 | Procainamide infusion test: inability to identify patients with Wolff-Parkinson-White syndrome who are potentially at risk of sudden death. ( Fananapazir, L; Gallagher, JJ; German, LD; Greer, GS; Packer, DL; Pressley, JC; Prystowsky, EN, 1988) |
| "In patients with the Wolff-Parkinson-White syndrome, intravenous ajmaline (50 mg administered over 3 minutes) or procainamide (10 mg/kg body weight administered over 10 minutes) is helpful in defining the duration of the anterograde effective refractory period of the accessory pathway." | 3.66 | Value of the ajmaline-procainamide test to predict the effect of long-term oral amiodarone on the anterograde effective refractory period of the accessory pathway in the Wolff-Parkinson-White syndrome. ( Braat, S; Brugada, P; Dassen, WR; Gorgels, AP; Wellens, HJ, 1983) |
| "Like ajmaline, procainamide can be used to identify patients with the Wolff-Parkinson-White syndrome who have a short refractory period of the accessory pathway in an anterograde direction." | 3.66 | Use of procainamide in patients with the Wolff-Parkinson-White syndrome to disclose a short refractory period of the accessory pathway. ( Bär, FW; Braat, S; Brugada, P; Gorgels, AP; Wellens, HJ, 1982) |
| "Thirty-three patients with Wolff-Parkinson-White syndrome were studied electrophysiologically before and after administration of intravenous procainamide and oral quinidine sulfate." | 3.65 | Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome. ( Bashore, TM; Campbell, RW; Gallagher, JJ; Sellers, TD, 1977) |
| " Circus tachycardia was induced by atrial stimulation only after the administration of procainamide." | 3.65 | Wolff-Parkinson-White syndrome. Circus movement tachycardia dependent on procainamide. ( Geddes, JS, 1977) |
| "We evaluated the electrophysiological mechanisms of adverse effects of class I antiarrhythmic drugs (cibenzoline in seven patients, pilsicainide in two, and disopyramide in two, and procainamide in three) in the induction of orthodromic atrioventricular re-entrant tachycardia (AVRT)." | 2.68 | Electrophysiologic mechanisms of adverse effects of class I antiarrhythmic drugs (cibenzoline, pilsicainide, disopyramide, procainamide) in induction of atrioventricular re-entrant tachycardia. ( Fujiki, A; Inoue, H; Tani, M; Yoshida, S, 1996) |
| "By nine weeks, one TG(N488I) mouse with WPW syndrome lost this phenotype, whereas TG(WT) pups never developed pre-excitation." | 1.32 | Electrophysiologic characterization and postnatal development of ventricular pre-excitation in a mouse model of cardiac hypertrophy and Wolff-Parkinson-White syndrome. ( Arad, M; Berul, CI; Branco, D; Maguire, CT; Moskowitz, IP; Patel, VV; Seidman, CE; Seidman, JG, 2003) |
| "The first tachycardia, as expected for bundle branch block ipsilateral to the bypass tract, had a longer cycle length (CL) than the original tachycardia (366 msec compared to 297 msec)." | 1.30 | Double-wave reentry in orthodromic atrioventricular reciprocating tachycardia: paradoxical shortening of the tachycardia cycle length with development of ipsilateral bundle branch block. ( Coromilas, J; Costeas, C; Dizon, J; Kassotis, J; Lipka, L; Reiffel, J, 1998) |
| "Patient 1 had frequent episodes of paroxysmal atrial fibrillation resistant to Class IA drugs." | 1.30 | ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome. ( Fujiki, A; Hayashi, H; Inoue, H; Mizumaki, K; Nagasawa, H; Usui, M, 1999) |
| " The effect of procainamide on the anterograde effective refractory period of the accessory pathway was dose dependent; patients who lost preexcitation had a steeper dose-response curve." | 1.28 | Value of a revised procainamide test in the Wolff-Parkinson-White syndrome. ( Boahene, KA; Fujimura, O; Klein, GJ; Sharma, AD; Yee, R, 1990) |
| "Conversion from right bundle branch block to left bundle branch block was reproducibly associated with the initiation of circus movement tachycardia utilizing the normal conducting system antegradely and the accessory pathway retrogradely." | 1.27 | An unusual mechanism of initiation of circus movement tachycardia in a patient with concealed Wolff-Parkinson-White syndrome. ( Stevenson, WG; Weiss, J, 1983) |
| "During AF in WPW syndrome, the ventricular rate is related to the duration of the anterograde refractory period of the accessory pathway." | 1.27 | Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome. ( Abdollah, H; Brugada, P; Wellens, HJ, 1983) |
| "In the manifest WPW syndrome, disopyramide or aprindine was indicated especially for patients with the accessory pathways of the short antegrade refractory period, because these drugs lengthened the refractory period of the accessory pathways." | 1.27 | Usefulness of invasive and non-invasive electrophysiologic studies in the selection of antiarrhythmic drugs for the patients with paroxysmal supraventricular tachyarrhythmia. ( Hiejima, K; Hirao, K; Kubo, I; Moroi, Y; Satake, S; Suzuki, F, 1985) |
| "In the WPW syndrome, significant prolongation of the P-X, P-J, P-T, P-C, P-I, P-Ao, and P-II intervals was induced by the drug." | 1.25 | Wolff-Parkinson-White syndrome: mechanocardiographic study on the mechanical consequences of ventricular pre-excitation. ( Hasegawa, S; Hoshika, Y; Ishikawa, H; Kagoshima, T; Yamao, H, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 78 (75.73) | 18.7374 |
| 1990's | 20 (19.42) | 18.2507 |
| 2000's | 3 (2.91) | 29.6817 |
| 2010's | 2 (1.94) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simonian, SM | 1 |
| Lotfipour, S | 1 |
| Wall, C | 1 |
| Langdorf, MI | 1 |
| De Rosa, F | 1 |
| Mancuso, P | 1 |
| Chiatto, M | 1 |
| Calvelli, A | 1 |
| De Donato, V | 1 |
| Mazza, S | 1 |
| Spadafora, G | 1 |
| Patel, VV | 1 |
| Arad, M | 1 |
| Moskowitz, IP | 1 |
| Maguire, CT | 1 |
| Branco, D | 1 |
| Seidman, JG | 1 |
| Seidman, CE | 1 |
| Berul, CI | 1 |
| ZAPATA DIAZ, J | 1 |
| CABRERA, E | 1 |
| RODRIGUEZ, MI | 1 |
| SODI PALLARES, D | 1 |
| LAVENNE, F | 1 |
| TYBERGHEIN, J | 1 |
| SONNET, J | 1 |
| CLOETENS, W | 1 |
| DE MEY, D | 1 |
| VAN HEES, CA | 2 |
| PITZUS, F | 1 |
| TUVERI, A | 1 |
| GARELLO, L | 1 |
| RAUTERBERG, W | 1 |
| KERKOVITS, G | 1 |
| ECSY, K | 1 |
| KURAMITSU, H | 1 |
| OBARA, Y | 1 |
| SASAKI, T | 1 |
| NAKANO, T | 1 |
| SATO, I | 1 |
| KUBOTA, R | 1 |
| SUGENO, H | 1 |
| MURAO, S | 1 |
| UEDA, H | 1 |
| HOMOLA, D | 1 |
| PUECH, P | 2 |
| LATOUR, H | 2 |
| HERTAULT, J | 1 |
| GROLLEAU, R | 1 |
| YAHINI, JH | 1 |
| ZAHAVI, I | 1 |
| NEUFELD, HN | 1 |
| CHUNG, KY | 1 |
| WALSH, TJ | 1 |
| MASSIE, E | 1 |
| GIRAUD, G | 1 |
| LEVY, A | 1 |
| BERTRAND, A | 1 |
| BONNET, H | 1 |
| HOFFMAN, I | 1 |
| ABERNATHY, RS | 1 |
| HAEDICKE, TA | 1 |
| Chew, HC | 1 |
| Lim, SH | 1 |
| Apostolov, L | 1 |
| Takác, M | 1 |
| Resetár, J | 1 |
| Takácová, M | 1 |
| Rozlozník, J | 1 |
| Orco, J | 1 |
| Frajt, J | 1 |
| Prystowsky, EN | 2 |
| Stevenson, WG | 1 |
| Weiss, J | 1 |
| Critelli, G | 1 |
| Gallagher, JJ | 5 |
| Perticone, F | 1 |
| Coltorti, F | 1 |
| Monda, V | 1 |
| Condorelli, M | 1 |
| Wang, JL | 1 |
| Hwang, YS | 1 |
| Jackman, WM | 1 |
| Friday, KJ | 1 |
| Scherlag, BJ | 1 |
| Dehning, MM | 1 |
| Schechter, E | 1 |
| Reynolds, DW | 1 |
| Olson, EG | 1 |
| Berbari, EJ | 1 |
| Harrison, LA | 1 |
| Lazzara, R | 1 |
| Wellens, HJ | 6 |
| Brugada, P | 4 |
| Abdollah, H | 1 |
| Skorobogatyĭ, AM | 1 |
| Fukatani, M | 1 |
| Kiya, F | 1 |
| Yano, K | 1 |
| Hashiba, K | 1 |
| Dassen, WR | 2 |
| Braat, S | 2 |
| Gorgels, AP | 2 |
| Lukoshevichiute, AI | 1 |
| Reĭngardene, DI | 1 |
| Goldberg, D | 1 |
| Reiffel, JA | 1 |
| Davis, JC | 2 |
| Gang, E | 1 |
| Livelli, F | 1 |
| Bigger, JT | 1 |
| Bauernfeind, RA | 1 |
| Swiryn, SP | 1 |
| Strasberg, B | 1 |
| Palileo, E | 1 |
| Scagliotti, D | 1 |
| Rosen, KM | 2 |
| Ankhimiuk, ON | 1 |
| Smolenskiĭ, VS | 1 |
| Izotov, BN | 1 |
| Andiiako, TB | 1 |
| Bär, FW | 2 |
| Nicolai, P | 1 |
| Medvedowsky, JL | 1 |
| Delaage, M | 1 |
| Barnay, C | 1 |
| Blache, E | 1 |
| Pisapia, A | 1 |
| Vanagt, EJ | 1 |
| Farré, J | 1 |
| Zimmers, T | 2 |
| Muramatsu, M | 1 |
| Nakajima, M | 1 |
| Mori, M | 1 |
| Sobashima, H | 1 |
| Sano, H | 1 |
| Katao, K | 1 |
| Chen, SA | 3 |
| Chiang, CE | 2 |
| Tai, CT | 3 |
| Lee, SH | 2 |
| Chiou, CW | 2 |
| Ueng, KC | 2 |
| Wen, ZC | 3 |
| Cheng, CC | 1 |
| Chang, MS | 3 |
| Chen, YJ | 1 |
| Yu, WC | 2 |
| Huang, JL | 1 |
| Sideris, AM | 1 |
| Galiatsu, E | 1 |
| Filippatos, GS | 1 |
| Kappos, K | 1 |
| Anthopoulos, LP | 1 |
| Fujiki, A | 2 |
| Tani, M | 1 |
| Yoshida, S | 1 |
| Inoue, H | 3 |
| Irwin, RS | 1 |
| Weg, JG | 1 |
| Mélon, P | 1 |
| Waleffe, A | 1 |
| Kulbertus, H | 1 |
| Coromilas, J | 1 |
| Kassotis, J | 1 |
| Dizon, J | 1 |
| Reiffel, J | 1 |
| Costeas, C | 1 |
| Lipka, L | 1 |
| Feng, AN | 1 |
| Ding, YA | 1 |
| Usui, M | 1 |
| Nagasawa, H | 1 |
| Mizumaki, K | 1 |
| Hayashi, H | 1 |
| Rosner, MH | 1 |
| Brady, WJ | 1 |
| Kefer, MP | 1 |
| Martin, ML | 1 |
| Niwano, S | 1 |
| Kitano, Y | 1 |
| Moriguchi, M | 1 |
| Izumi, T | 1 |
| Forester, D | 1 |
| Polimeni, RM | 1 |
| Abate, G | 1 |
| Zacà, F | 1 |
| Alberici, S | 1 |
| Cremonesi, A | 1 |
| Pagliarani, PL | 1 |
| Costa, G | 1 |
| Guelpi, P | 1 |
| Pavesi, PC | 1 |
| Lenzi, S | 1 |
| Sellers, TD | 1 |
| Campbell, RW | 1 |
| Bashore, TM | 1 |
| Geddes, JS | 1 |
| Durrer, D | 2 |
| Tonkin, AM | 1 |
| Wallace, AG | 2 |
| Kahn, A | 1 |
| Morris, JJ | 1 |
| Citron, P | 1 |
| Sugimoto, T | 1 |
| Osada, S | 1 |
| Gilbert, M | 1 |
| Svenson, RH | 1 |
| Sealy, WC | 1 |
| Kasell, J | 1 |
| Hoffman, BF | 1 |
| Rosen, MR | 1 |
| Wit, AL | 1 |
| Ishikawa, H | 1 |
| Kagoshima, T | 1 |
| Hasegawa, S | 1 |
| Hoshika, Y | 1 |
| Yamao, H | 1 |
| Mandel, WJ | 1 |
| Laks, MM | 1 |
| Obayashi, K | 1 |
| Hayakawa, H | 1 |
| Daley, W | 1 |
| Josephson, ME | 1 |
| Kastor, JA | 1 |
| Kitchen, JG | 1 |
| Leitch, JW | 1 |
| Klein, GJ | 3 |
| Yee, R | 3 |
| Feldman, RD | 1 |
| Brown, J | 1 |
| Li, P | 1 |
| Nii, T | 1 |
| Nakashima, Y | 1 |
| Nomoto, J | 1 |
| Hiroki, T | 1 |
| Ohshima, F | 1 |
| Arakawa, K | 1 |
| Hancock, EW | 1 |
| Valle, BK | 1 |
| Lemberg, L | 1 |
| Boahene, KA | 2 |
| Sharma, AD | 2 |
| Fujimura, O | 3 |
| Kuo, CS | 1 |
| Smith, BA | 1 |
| Eldar, M | 1 |
| Ruder, MA | 1 |
| Abbott, JA | 1 |
| Seger, J | 1 |
| Griffin, JC | 1 |
| Scheinman, MM | 1 |
| Ma, F | 1 |
| Gaita, F | 1 |
| Giustetto, C | 1 |
| Riccardi, R | 1 |
| Mangiardi, L | 1 |
| Brusca, A | 1 |
| Fananapazir, L | 1 |
| Packer, DL | 1 |
| German, LD | 1 |
| Greer, GS | 1 |
| Pressley, JC | 1 |
| Zipes, DP | 1 |
| Satake, S | 1 |
| Hiejima, K | 1 |
| Moroi, Y | 1 |
| Hirao, K | 1 |
| Kubo, I | 1 |
| Suzuki, F | 2 |
| Laufer, N | 1 |
| Crevey, B | 1 |
| Hurwitz, RA | 1 |
| Ferrer, MI | 1 |
| Krikler, DM | 1 |
| Robinson, SJ | 1 |
| Donat, K | 1 |
| Brackbill, TA | 1 |
| Dove, JT | 1 |
| Murphy, GW | 1 |
| Barold, SS | 1 |
| Dhingra, RC | 1 |
| Spracklen, FH | 1 |
| Witham, AC | 1 |
| Beck, E | 1 |
| Bracchetti, D | 1 |
| Binetti, G | 1 |
| D'Osualdo, F | 1 |
| Magnani, B | 1 |
| Lim, CH | 1 |
| Toh, CC | 1 |
| Chia, BL | 1 |
| Narula, OS | 1 |
| Pilotti, G | 1 |
| Ricci, C | 1 |
| Isaeff, DM | 1 |
| Gaston, JH | 1 |
| Harrison, DC | 1 |
| Harumi, K | 1 |
| Matsuo, H | 1 |
| Chen, CM | 1 |
| Touche, M | 1 |
| Jouvet, M | 1 |
| Touche, S | 1 |
| Gomes de Carvalho, A | 1 |
| Chou, TC | 1 |
| Timio, M | 1 |
| Kon'kov, AV | 1 |
| Bogatyreva, AP | 1 |
| Byrd, RB | 1 |
| Schanzer, B | 1 |
| Tronconi, L | 1 |
11 reviews available for procainamide and Anomalous Ventricular Excitation Syndrome
| Article | Year |
|---|---|
Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Emergency Servi | 2010 |
[Ventricular preexcitation: is risk stratification feasible?].
Topics: Adolescent; Adult; Age Distribution; Ajmaline; Atrioventricular Node; Catheter Ablation; Child; Chil | 2010 |
Pharmacologic therapy of tachyarrhythmias in patients with Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ajmaline; Amiodarone; Anilides; Aprindine; Atr | 1983 |
[Value of drug tests in Wolff-Parkinson-White syndrome].
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrioventricular Node; Diagnosis, Differential; Electr | 1981 |
Cardiac arrhythmias in infants and children.
Topics: Adolescent; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Bradycardi | 1973 |
Pre-excitation syndrome: mechanisms and treatment.
Topics: Action Potentials; Cardiac Complexes, Premature; Digoxin; Electrocardiography; Heart; Heart Atria; H | 1970 |
Treatment of cardiac arrhythmias.
Topics: Adams-Stokes Syndrome; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; | 1964 |
The diagnosis of myocardial infarction in the Wolff-Parkinson-White syndrome.
Topics: Adult; Aged; Amyl Nitrite; Arrhythmias, Cardiac; Bundle-Branch Block; Electrocardiography; Exercise | 1974 |
Wolff-Parkinson-White Syndrome. A review.
Topics: Adult; Ajmaline; Atropine; Cardiac Catheterization; Digitalis Glycosides; Electric Stimulation; Elec | 1973 |
[Wolff-Parkinson-White syndrome and paroxysmal tachycardia in infancy. Case report and review of literature].
Topics: Age Factors; Ajmaline; Electrocardiography; Humans; Infant; Male; Procainamide; Quinidine; Sex Facto | 1974 |
[Electrocardiography of the bundle of His].
Topics: Electrocardiography; Heart Atria; Heart Block; Heart Conduction System; Heart Ventricles; Humans; Li | 1971 |
3 trials available for procainamide and Anomalous Ventricular Excitation Syndrome
| Article | Year |
|---|---|
Effects of magnesium and potassium on Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Conduction Syste | 1996 |
Electrophysiologic mechanisms of adverse effects of class I antiarrhythmic drugs (cibenzoline, pilsicainide, disopyramide, procainamide) in induction of atrioventricular re-entrant tachycardia.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Disopyramide; Electrophysiology; Female; Heart Cond | 1996 |
Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: importance of atrial fibrillatory cycle length.
Topics: Adolescent; Adult; Aged; Atrial Fibrillation; Echocardiography; Female; Humans; Male; Middle Aged; P | 1990 |
89 other studies available for procainamide and Anomalous Ventricular Excitation Syndrome
| Article | Year |
|---|---|
Electrophysiologic characterization and postnatal development of ventricular pre-excitation in a mouse model of cardiac hypertrophy and Wolff-Parkinson-White syndrome.
Topics: Adenosine; Age Factors; AMP-Activated Protein Kinases; Animals; Anti-Arrhythmia Agents; Biopsy; Card | 2003 |
[Action of procaine amide (pronestyl) on the heart. IV. Wolff-Parkinson-White syndrome and procaine amide].
Topics: Cardiovascular Diseases; Heart; Heart Block; Procainamide; Procaine; Wolff-Parkinson-White Syndrome | 1953 |
[Effect of procaine amide on Wolff-Parkinson-White syndrome].
Topics: Cardiovascular Diseases; Heart Block; Humans; Procainamide; Procaine; Wolff-Parkinson-White Syndrome | 1953 |
[Special development of a Wolff-Parkinson-White syndrome; the pharmacological effect of procaine amide].
Topics: Cardiovascular Diseases; Heart Block; Humans; Procainamide; Rheumatic Heart Disease; Wolff-Parkinson | 1953 |
[Effect of procaine amide on the Wolff-Parkinson-White syndrome].
Topics: Cardiovascular Diseases; Heart Block; Humans; Procainamide; Wolff-Parkinson-White Syndrome | 1953 |
[Effects of procaine amide in Wolff-Parkinson-White syndrome].
Topics: Cardiovascular Diseases; Heart Block; Humans; Procainamide; Wolff-Parkinson-White Syndrome | 1954 |
[Effect of procaine amide on Wolff-Parkinson-White syndrome].
Topics: Anti-Arrhythmia Agents; Cardiovascular Diseases; Enzyme Inhibitors; Heart Block; Humans; Procainamid | 1955 |
[Effect of procaine amide in Wolff-Parkinson-White syndrome].
Topics: Anti-Arrhythmia Agents; Cardiotonic Agents; Heart; Heart Block; Humans; Procainamide; Wolff-Parkinso | 1955 |
[Novocamid therapy in Wolff-Parkinson-White syndrome].
Topics: Heart; Heart Block; Humans; Niacin; Nicotinic Acids; Procainamide; Wolff-Parkinson-White Syndrome | 1958 |
[Data on the genesis of the Wolff-Parkinson-White (WPW) syndrome].
Topics: Humans; Procainamide; Wolff-Parkinson-White Syndrome | 1963 |
[ON THE W. P. W. SYNDROME. REPORT OF 22 CASES].
Topics: Adolescent; Cardiovascular Diseases; Child; Electrocardiography; Geriatrics; Humans; Japan; Procaina | 1963 |
WPW SYNDROME ON BOVINE; A CASE REPORT.
Topics: Animals; Calcium; Calcium, Dietary; Cardiac Catheterization; Cattle; Cattle Diseases; Electrocardiog | 1964 |
A CASE OF VENTRICULAR TACHYCARDIA INTRODUCED BY COMBINED TACHYCARDIA WITH WPW COMPLEXES AND EVOKED BY ORTHOSTASIS.
Topics: Cardiac Complexes, Premature; Dizziness; Drug Therapy; Electrocardiography; Humans; Posture; Procain | 1964 |
[INJECTABLE ADMALINE IN PAROXYSMAL TACHYCARDIA AND THE W.P.W. SYNDROME. COMPARISON WITH PROCAINE AMIDE].
Topics: Alkaloids; Electrocardiography; Humans; Procainamide; Rauwolfia; Tachycardia; Tachycardia, Paroxysma | 1964 |
PAROXYSMAL ATRIAL FIBRILLATION IN WOLFF-PARKINSON-WHITE SYNDROME SIMULATING VENTRICULAR TACHYCARDIA.
Topics: Atrial Fibrillation; Diagnosis, Differential; Digoxin; Electrocardiography; Humans; Procainamide; Pr | 1964 |
WOLFF-PARKINSON-WHITE SYNDROME.
Topics: Arrhythmias, Cardiac; Digitalis Glycosides; Drug Therapy; Electric Countershock; Electrocardiography | 1965 |
[Prolonged paroxysmal tachycardia of the arterioventricular node during Wolff-Parkinson-White syndrome; failure of procaine amide; effectivity of intravenous chlorpromazine].
Topics: Cardiovascular Diseases; Chlorpromazine; Heart Block; Procainamide; Tachycardia; Tachycardia, Paroxy | 1954 |
Effect of procaine amide on anomalous conduction and paroxysmal tachycardia in a case resembling the Wolff-Parkinson-White syndrome.
Topics: Arrhythmias, Cardiac; Humans; Procainamide; Procaine; Tachycardia; Tachycardia, Paroxysmal; Wolff-Pa | 1952 |
Broad complex atrial fibrillation.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Electric Countershock; | 2007 |
[On a new pharmacologic test in the Wolff-Parkinson-White syndrome].
Topics: Adolescent; Adult; Electrocardiography; Female; Humans; Male; Middle Aged; Plants, Medicinal; Procai | 1967 |
[Contribution to the diagnosis and treatment of paroxysmal tachycardia in Wolff-Parkinson-White syndrome].
Topics: Electrocardiography; Humans; Magnesium Sulfate; Procainamide; Propranolol; Tachycardia, Paroxysmal; | 1967 |
An unusual mechanism of initiation of circus movement tachycardia in a patient with concealed Wolff-Parkinson-White syndrome.
Topics: Adult; Bundle-Branch Block; Electrocardiography; Humans; Male; Procainamide; Tachycardia; Wolff-Park | 1983 |
Evaluation of noninvasive tests for identifying patients with preexcitation syndrome at risk of rapid ventricular response.
Topics: Adult; Aged; Ajmaline; Atrial Fibrillation; Cardiac Pacing, Artificial; Electrocardiography; Female; | 1984 |
Paroxysmal atrial fibrillation in Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Aged; Atrial Fibrillation; Female; Follow-Up Studies; Humans; Male; Middle Aged; | 1983 |
Direct endocardial recording from an accessory atrioventricular pathway: localization of the site of block, effect of antiarrhythmic drugs, and attempt at nonsurgical ablation.
Topics: Adult; Anti-Arrhythmia Agents; Atrioventricular Node; Cardiac Pacing, Artificial; Disopyramide; Ebst | 1983 |
Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome.
Topics: Ajmaline; Amiodarone; Atrial Fibrillation; Benzofurans; Electrophysiology; Heart; Humans; Isoprotere | 1983 |
[Diagnosis of the early ventricular repolarization syndrome].
Topics: Adult; Aged; Electrocardiography; Female; Humans; Male; Middle Aged; Procainamide; Wolff-Parkinson-W | 1984 |
Paradoxical effects of procainamide--facilitation of the induction of sustained reciprocating tachycardia after procainamide administration in Wolff-Parkinson-White syndrome.
Topics: Female; Heart Rate; Humans; Male; Procainamide; Refractory Period, Electrophysiological; Tachycardia | 1983 |
Value of the ajmaline-procainamide test to predict the effect of long-term oral amiodarone on the anterograde effective refractory period of the accessory pathway in the Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Ajmaline; Amiodarone; Benzofurans; Electrophysiology; Female; Heart Conduction Sy | 1983 |
Electrophysiologic effects of procainamide on sinus function in patients with and without sinus node disease.
Topics: Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Bradycardia; Female; Humans; Male; Middle Ag | 1982 |
Electrophysiologic drug testing in prophylaxis of sporadic paroxysmal atrial fibrillation: technique, application, and efficacy in severely symptomatic preexcitation patients.
Topics: Administration, Oral; Adolescent; Adult; Aprindine; Atrial Fibrillation; Cardiac Pacing, Artificial; | 1982 |
[Novocainamide in the treatment of paroxysmal supraventricular tachycardia and auricular fibrillation in premature ventricular excitation syndrome (relation between novocainamide dose, its blood level, and antiarrhythmia effect)].
Topics: Adult; Aged; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Administration Schedule; Fe | 1982 |
Use of procainamide in patients with the Wolff-Parkinson-White syndrome to disclose a short refractory period of the accessory pathway.
Topics: Adolescent; Adult; Aged; Ajmaline; Child; Electrocardiography; Female; Heart Conduction System; Huma | 1982 |
Wolff-Parkinson-White syndrome: T wave abnormalities during normal pathway conduction.
Topics: Adolescent; Adult; Aged; Ajmaline; Child; Electrocardiography; Female; Heart Conduction System; Huma | 1981 |
Effect of drugs in the Wolff-Parkinson-White syndrome. Importance of initial length of effective refractory period of the accessory pathway.
Topics: Accessory Nerve; Adolescent; Adult; Ajmaline; Amiodarone; Child; Female; Heart Block; Humans; Male; | 1980 |
Cases in electrocardiography.
Topics: Accelerated Idioventricular Rhythm; Adolescent; Adult; Electrocardiography; Humans; Male; Myocardial | 1993 |
[A case of primary antiphospholipid antibody syndrome associated with procainamide induced systemic lupus erythematosus].
Topics: Aged; Anti-Arrhythmia Agents; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Female; Human | 1995 |
Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular N | 1996 |
Electrophysiologic characteristics, electropharmacologic responses and radiofrequency ablation in patients with decremental accessory pathway.
Topics: Adenosine; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrioventricular Node | 1996 |
A man with a prolonged episode of palpitations.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Humans; Male; Procainamide; | 1996 |
[Wolff-Parkinson-White syndrome accompanying rapid conduction atrial fibrillation].
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Death, Sudden, Cardiac; Elect | 1997 |
Double-wave reentry in orthodromic atrioventricular reciprocating tachycardia: paradoxical shortening of the tachycardia cycle length with development of ipsilateral bundle branch block.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Bundle-Branch Block; Cardiac Pacing, Artificial; | 1998 |
Effects of procainamide and dl-sotalol on the changes of atrial electrophysiology induced by high current stimulation.
Topics: Adult; Aged; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Function; Atrial Premature Complex | 1998 |
ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Flecainide; Follow-Up Studies; Hea | 1999 |
Electrocardiography in the patient with the Wolff-Parkinson-White syndrome: diagnostic and initial therapeutic issues.
Topics: Adult; Anti-Arrhythmia Agents; Child, Preschool; Combined Modality Therapy; Diagnosis, Differential; | 1999 |
Transient appearance of antegrade conduction via an AV accessory pathway caused by atrial fibrillation in a patient with intermittent Wolff-Parkinson-White syndrome.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Electrocardiography | 2000 |
Treatment of arrhythmias in the Wolff-Parkinson-White syndrome.
Topics: Administration, Oral; Atrial Fibrillation; Disopyramide; Humans; Injections, Intravenous; Lidocaine; | 1979 |
[Prophylactic therapy of attacks of tachycardia in Wolff-Parkinson-White syndrome].
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Pindolol; Procainamide; Tachycardia; Wolff-Parkinson | 1977 |
Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome.
Topics: Atrial Fibrillation; Electrophysiology; Female; Humans; Male; Procainamide; Quinidine; Wolff-Parkins | 1977 |
Wolff-Parkinson-White syndrome. Circus movement tachycardia dependent on procainamide.
Topics: Electric Stimulation; Heart Atria; Humans; Male; Middle Aged; Procainamide; Tachycardia; Wolff-Parki | 1977 |
Medical and surgical treatment of the Wolff-Parkinson-White syndrome.
Topics: Digoxin; Humans; Methods; Procainamide; Propranolol; Quinidine; Secologanin Tryptamine Alkaloids; Wo | 1976 |
Tachyarrhythmias in Wolff-Parkinson-White syndrome. Treatment and prevention.
Topics: Adult; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Bundle of His; Child; Drug Therapy | 1976 |
Patient-initiated rapid atrial pacing to manage supraventricular tachycardia.
Topics: Adult; Aged; Atrial Fibrillation; Digoxin; Heart Rate; Humans; Male; Middle Aged; Pacemaker, Artific | 1976 |
Mechanism of supraventricular tachycardia and pharmacological effects on it.
Topics: Heart Conduction System; Heart Rate; Humans; Procainamide; Propranolol; Tachycardia; Wolff-Parkinson | 1976 |
Wolff-Parkinson-White syndrome. The problem, evaluation, and surgical correction.
Topics: Adolescent; Adult; Atrial Fibrillation; Cardiopulmonary Bypass; Ebstein Anomaly; Electrocardiography | 1975 |
Electrophysiology and pharmacology of cardiac arrhythmias. VII. Cardiac effects of quinidine and procaine amide. A.
Topics: Administration, Oral; Arrhythmias, Cardiac; Bundle of His; Heart Conduction System; Humans; Infusion | 1975 |
Effect of drugs in the wolff-parkinson-white syndrome.
Topics: Ajmaline; Digitalis Glycosides; Electric Stimulation; Humans; Lidocaine; Procainamide; Propranolol; | 1975 |
Wolff-Parkinson-White syndrome: mechanocardiographic study on the mechanical consequences of ventricular pre-excitation.
Topics: Adult; Heart Conduction System; Heart Ventricles; Humans; Kinetocardiography; Middle Aged; Myocardia | 1975 |
The Wolff-Parkinson-White syndrome: pharmacologic effects of procaine amide.
Topics: Adolescent; Adult; Female; Heart Conduction System; Humans; Male; Middle Aged; Procainamide; Tachyca | 1975 |
Lidocaine in Wolff-Parkinson-White syndrome with atrial fibrillation.
Topics: Adolescent; Atrial Fibrillation; Electrocardiography; Hospitalization; Humans; Lidocaine; Male; Proc | 1976 |
Differential effect of intravenous procainamide on anterograde and retrograde accessory pathway refractoriness.
Topics: Adult; Atrioventricular Node; Blood Pressure; Cardiac Pacing, Artificial; Dose-Response Relationship | 1992 |
[Electrophysiological properties of atrial fibrillation with WPW syndrome and the role of procainamide in conversion].
Topics: Adolescent; Adult; Atrial Fibrillation; Child; Child, Preschool; Electric Stimulation; Electrocardio | 1991 |
Normalization of reverse redistribution of thallium-201 with procainamide pretreatment in Wolff-Parkinson-White syndrome.
Topics: Adult; Atrioventricular Node; Coronary Circulation; Female; Humans; Procainamide; Thallium Radioisot | 1991 |
Ventricular or supraventricular tachycardia?
Topics: Adult; Diagnosis, Differential; Electrocardiography; Humans; Male; Procainamide; Tachycardia; Tachyc | 1990 |
Wolff-Parkinson-White syndrome.
Topics: Adult; Electrocardiography; Electrophysiology; Heart Conduction System; Humans; Injections, Intraven | 1990 |
Preexcited tachycardia due to atrioventricular node reentry with a bystander accessory pathway diagnosed after procainamide infusion.
Topics: Adolescent; Atrioventricular Node; Electrocardiography; Electrophysiology; Humans; Male; Procainamid | 1990 |
Value of a revised procainamide test in the Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Aged; Atrial Fibrillation; Dose-Response Relationship, Drug; Electrocardiography; | 1990 |
Procainamide-induced incessant supraventricular tachycardia in the Wolff-Parkinson-White syndrome.
Topics: Electrophysiology; Female; Humans; Middle Aged; Procainamide; Tachycardia; Wolff-Parkinson-White Syn | 1986 |
Cases in electrocardiography.
Topics: Adult; Electrocardiography; Emergencies; Female; Humans; Male; Middle Aged; Pacemaker, Artificial; P | 1989 |
Stress and pharmacologic tests as methods to identify patients with Wolff-Parkinson-White syndrome at risk of sudden death.
Topics: Adolescent; Adult; Child; Death, Sudden; Exercise Test; Female; Humans; Male; Middle Aged; Procainam | 1989 |
Procainamide infusion test: inability to identify patients with Wolff-Parkinson-White syndrome who are potentially at risk of sudden death.
Topics: Atrial Fibrillation; Cardiac Pacing, Artificial; Death, Sudden; Electrocardiography; Evaluation Stud | 1988 |
Conduction over an isthmus of atrial myocardium in vivo: a possible model of Wolff-Parkinson-White syndrome.
Topics: Animals; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Dogs; Electrocardiography; | 1987 |
Usefulness of invasive and non-invasive electrophysiologic studies in the selection of antiarrhythmic drugs for the patients with paroxysmal supraventricular tachyarrhythmia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Bundle of His; Disopyramide; | 1985 |
Atrial fibrillation in the Wolff-Parkinson-White syndrome: effects of verapamil and procainamide.
Topics: Atrial Fibrillation; Drug Therapy, Combination; Electrocardiography; Humans; Male; Middle Aged; Proc | 1985 |
A fresh look at cardiac arrhythmias. Therapy.
Topics: Action Potentials; Adrenergic beta-Antagonists; Ajmaline; Anti-Arrhythmia Agents; Arrhythmias, Cardi | 1974 |
[The attack-like heart gallop].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; Cardiac Gly | 1968 |
His-bundle electrography. Clinical applications. Second of two parts.
Topics: Atrioventricular Node; Bundle of His; Digitalis; Electrocardiography; Glucagon; Heart Conduction Sys | 1974 |
Pre-excitation of the right branch of the bundle of His. A new electrocardiographic syndrome.
Topics: Arrhythmias, Cardiac; Atropine; Bundle-Branch Block; Child; Diagnosis, Differential; Electrocardiogr | 1974 |
[Contraindications to the use of digitalis in atrial fibrillation in the course of Wolff-Parkinson-White syndrome].
Topics: Aged; Atrial Fibrillation; Digoxin; Electrocardiography; Hemodynamics; Humans; Lidocaine; Male; Prac | 1974 |
Ventricular fibrillation in type B Wolff-Parkinson-White syndrome.
Topics: Adult; Female; Humans; Lidocaine; Pacemaker, Artificial; Practolol; Procainamide; Recurrence; Ventri | 1974 |
Wolff-Parkinson-White syndrome. Long-term monitoring for arrhythmias.
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Catheterization; Digoxin; Elec | 1972 |
Effect of procaine amide, quinidine, and ajmaline in the Wolff-Parkinson-White syndrome.
Topics: Adult; Ajmaline; Electrocardiography; Electrophysiology; Female; Heart Atria; Heart Block; Heart Con | 1974 |
[Ventricular fibrillation in Wolff-Parkinson-White syndrome. Reduction by external electric shock].
Topics: Adult; Electric Countershock; Humans; Male; Procainamide; Tachycardia, Paroxysmal; Ventricular Fibri | 1966 |
W-P-W syndrome and tachycardia.
Topics: Atrial Fibrillation; Diagnosis, Differential; Digitalis Glycosides; Humans; Procainamide; Tachycardi | 1970 |
Atrial and nodal (junctional) tachycardia.
Topics: Diagnosis, Differential; Digitalis Glycosides; Electrocardiography; Humans; Infant; Male; Neostigmin | 1970 |
[The Wolff-Parkinson-White syndrome. Contribution to the therapeutic study].
Topics: Adult; Female; Humans; Male; Phytotherapy; Plants, Medicinal; Procainamide; Quinidine; Rauwolfia; Sa | 1967 |
[Wolff-Parkinson-White syndrome].
Topics: Adolescent; Adult; Female; Humans; Male; Procainamide; Wolff-Parkinson-White Syndrome | 1967 |
Pulmonary sequelae in procaine amide induced lupus-like syndrome.
Topics: Adult; Diagnosis, Differential; Drug Hypersensitivity; Humans; Lung Diseases; Lupus Erythematosus, S | 1969 |
[Use of ajmaline by venous route and of procaine amide in the treatment of Wolff-Parkinson-White syndrome].
Topics: Adolescent; Adult; Female; Humans; Male; Middle Aged; Phytotherapy; Plants, Medicinal; Procainamide; | 1966 |